Gene encoding labyrinthin, a marker for cancer
AssigneeImmvaRx, Inc.
InventorJames Radosevich
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmvaRx, Inc.
InventorJames Radosevich
Estimating the term…
A cDNA molecule that encodes a protein designated Labyrinthin (Lab) is isolated and its nucleotide sequence is determined. The protein, or peptides derived from the protein, are markers useful to define novel classes of cancers. Diagnostic assays for these cancers use antibodies to Lab or nucleotide probes that hybridize with the lab gene or a fragment therefrom. Vaccines useful either to prevent recurrence of cancers in subjects who test positive for Lab (or lab), or to prevent initial occurrence of cancer, use proteins or peptides derived for Lab. Expression of Lab via immunogenic assays is used to monitor effects of cancer treatments. Antisense molecules against lab are used in treatments. Sense molecules of lab are used to restore lost lab function in diseased normal cells, for example, gland cells.
An isolated cDNA molecule with a nucleotide sequence as shown in FIG. 1.
An isolated cDNA molecule with a nucleotide sequence showing about 70% homology to the nucleotide sequence in FIG. 1.
A segment of the isolated cDNA sufficient to encode an epitope in the Lab protein detectable by the antibody MCA 44-3A6.
6-17. (canceled)
A vector comprising a cDNA molecule that encodes an amino acid sequence selected from the group consisting of APPEDNPVED, EEQQEVPPDT, DGPTGEPQQE, EQENPDSSEPV, and PTGEPQ.
Dependencies are inferred from the claim text.